Skip to content
The Nexus
DossierENTITY

Biotech companies

Coverage of Biotech companies in the Nexus archive.

Earliest in view: Jun 22 · 08:30 UTCMost recent: Jul 2 · 11:00 UTC
Co-mentioned in this coverage
Linda Shuperson1HSBCorganization1Chinaplace1United Statesplace1AI drug-designtopic1pharmaceutical companiestopic1Blockbuster M&A dealstopic12025topic1
Recent coverage
  • BUSINESSJul 2 · 11:00 UTCSCMP WORLD
    China AI drug-design deals swell as US scrutiny mounts

    Chinese AI-driven drug-design firms are securing global deals despite US scrutiny, with out-licensing deals reaching $75 billion in the first five months of 2026, up from zero before 2020.

  • BUSINESSJun 22 · 08:30 UTCSTAT NEWS
    STAT+: Pharma goes on a spending spree, snapping up biotechs in a hurry

    Pharmaceutical companies have acquired 32 biotech companies valued at $1 billion or more in the past six months, spending around $123 billion. This spending surpasses last year's totals in roughly half the time, with 26 blockbuster M&A deals in 2025 totaling $112 billion.

Biotech companies · Dossier · The Nexus